World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
68907
World Ranking
4277
National Ranking
2338

Eugene R. Schiff publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Eugene R. Schiff sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 595 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Eugene R. Schiff D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Eugene R. Schiff sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 116 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Eugene R. Schiff is affiliated with the University of Miami in the United States. Their research work primarily focuses on Medicine, with specific expertise in Epidemiology, Hepatology, and Infectious Diseases. They have also contributed to studies in Endocrinology, Diabetes and Metabolism, as well as Cardiology and Cardiovascular Medicine.

The main topics covered in Eugene R. Schiff's publications include:

  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Liver Disease Diagnosis and Treatment
  • Hepatitis Viruses Studies and Epidemiology
  • Diet, Metabolism, and Disease
  • Lipid metabolism and disorders
  • Liver Disease and Transplantation

They have published extensively in the following venues:

  • Journal of Hepatology (6 publications)
  • Hepatology (1 publication)
  • Journal of Viral Hepatitis (1 publication)
  • Liver Transplantation (1 publication)
  • JHEP Reports (1 publication)

Notable recent papers authored or coauthored by Eugene R. Schiff include:

  • "Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial" (2021, Hepatology)
  • "The case for simplifying and using absolute targets for viral hepatitis elimination goals" (2020, Journal of Viral Hepatitis)
  • "Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection" (2022, Journal of Hepatology)
  • "Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection" (2022, Journal of Hepatology)
  • "Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-positive chronic hepatitis B infection in a long-term extension study" (2020, Journal of Hepatology)

Frequently collaborating coauthors include:

  • Paul Y. Kwo (8 publications)
  • Mark Sulkowski (7 publications)
  • Ronald Nahass (7 publications)
  • Edward Gane (7 publications)
  • Ira M. Jacobson (7 publications)

Best Publications

  • Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

    John G. Mchutchison;Stuart C. Gordon;Eugene R. Schiff;Mitchell L. Shiffman

  • Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

    George Ostapowicz;Robert J. Fontana;Frank V. Schioødt;Anne Larson

  • Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

    Arie Regev;Mariana Berho;Lennox J. Jeffers;Clara Milikowski

  • Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

    Davis Gl;Balart La;Schiff Er;Lindsay K

  • Lamivudine as initial treatment for chronic hepatitis B in the United States.

    Jules L. Dienstag;Eugene R. Schiff;Teresa L. Wright;Robert P. Perrillo

  • Diseases of the liver

    Leon Schiff;Eugene R. Schiff

  • Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.

    John G. McHutchison;Eric J. Lawitz;Mitchell L. Shiffman;Andrew J. Muir

  • Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

    Nezam Afdhal;K. Rajender Reddy;David R. Nelson;Eric Lawitz

  • Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

    Kris V. Kowdley;Stuart C. Gordon;K. Rajender Reddy;Lorenzo Rossaro

  • Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

    Ira M. Jacobson;Stuart C. Gordon;Kris V. Kowdley;Eric M. Yoshida

  • Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

    Ting Tsung Chang;Yun Fan Liaw;Shun Sheng Wu;Eugene Schiff

  • A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection

    Jules L. Dienstag;Robert P. Perrillo;Eugene R. Schiff;Maria Bartholomew

  • Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

    Anna S.F. Lok;Ching Lung Lai;Nancy Leung;Guang Bi Yao

  • A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

    Robert P. Perrillo;Eugene R. Schiff;Gary L. Davis;Henry C. Bodenheimer

  • Histological outcome during long-term lamivudine therapy.

    Jules L. Dienstag;Robert D. Goldin;E.Jenny Heathcote;H.W.L. Hann

  • Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

    Paul Y Kwo;Eric J Lawitz;Jonathan McCone;Eugene R Schiff

  • A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

    Karen L. Lindsay;Christian Trepo;Tobias Heintges;Mitchell L. Shiffman

  • Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

    Michael Charlton;Gregory T. Everson;Steven L. Flamm;Princy Kumar

  • Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B

    Ching Lung Lai;Jules Dienstag;Eugene Schiff;Nancy W.Y. Leung

  • National Institutes of Health Consensus Development Conference panel statement: Management of hepatitis C

    D. W. Powell;B. Z. Abramson;J. A. Balint;S. Belle

Frequent Co-Authors

Andreas G. Tzakis
Andreas G. Tzakis Cleveland Clinic
K. Rajender Reddy
K. Rajender Reddy University of Pennsylvania
Ira M. Jacobson
Ira M. Jacobson New York University
Mitchell L. Shiffman
Mitchell L. Shiffman Bon Secours Health System
Jules L. Dienstag
Jules L. Dienstag Harvard University
Joshua Miller
Joshua Miller Northwestern University
William M. Lee
William M. Lee The University of Texas Southwestern Medical Center
Paul Martin
Paul Martin University of Miami
Mark S. Sulkowski
Mark S. Sulkowski Johns Hopkins University School of Medicine
Eric Lawitz
Eric Lawitz The University of Texas at Austin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA opens doors to various related fields and flexible study options. Many students seek alternatives to traditional, in-person programs, especially if they need to balance work with education. Fortunately, online degrees and bridge programs can offer accelerated and convenient pathways for career advancement.

Nursing is a popular starting point, with many schools now providing lpn to rn programs without teas test requirements—making it easier for licensed practical nurses to advance. For those who want to move into leadership roles, enrolling in a healthcare administration degree online accredited can prepare you for management positions without sacrificing flexibility.

Registered nurses can further specialize through rn to np programs, which provide a bridge to advanced practice and nurse practitioner roles. Meanwhile, those interested in preventive care and wellness may consider online nutrition degree programs that can lead to careers in clinical nutrition, public health, or education.

These online options offer flexibility, career growth, and access to high-demand healthcare roles—making them valuable pathways for anyone committed to the medical field.

Best Scientists Citing Eugene R. Schiff

Trending Scientists

Recently Published Articles